Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. - Wikidata - awgldk - TriplyDB

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

http://www.wikidata.org/entity/Q34159164

about

Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications My approach to the treatment of scleroderma Systemic Sclerosis and Malignancy: A Review of Current Data Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Small Cell Lung Cancer in a 20-year-old Non-Smoking Man with Systemic Sclerosis.Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.Review: cancer-induced autoimmunity in the rheumatic diseases.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.Squamous Cell Lung Cancer Associated With Systemic Sclerosis.Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.RNA polymerase III repression by the retinoblastoma tumor suppressor protein.PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.RNA Polymerase III Advances: Structural and tRNA Functional Views.Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome - description of two cases.Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer.Recurrent metastatic breast cancer presenting with paraneoplastic scleroderma.Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.Molecular and cellular basis of scleroderma.The role of the acquired immune response in systemic sclerosis.Cytokines in the immunopathology of systemic sclerosis.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature.An update on biomarker discovery and use in systemic sclerosis.Association of the autoimmune disease scleroderma with an immunologic response to cancer.Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.Scleroderma-related interstitial lung disease.RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.Why target the tumor stroma in melanoma?Anti-RNA polymerase III antibody positive limited cutaneous systemic sclerosis with cryoglobulin-induced digital gangrene.

P2860

Q24605267-DE2485A1-2529-4E0D-9D08-B2A9C623674C Q24618843-6FA9CB08-2562-4DD2-ACE4-90E35AF2C129 Q26740318-4E223E44-4C21-4B05-8513-4D2C3A3B3208 Q26995764-CA7FD6E0-8453-44D9-96BB-7809275CC5E4 Q28088499-735A3CDA-F14A-4994-AC7C-CF2029E64C43 Q30252086-EA7D1182-D84A-47D8-AE1E-3F6227B37180 Q33894752-9E38148A-1D42-4299-A9A5-05F65BBEE80E Q34107962-2B16F96A-0AA1-47A7-9C0F-0C66E062360B Q34128485-ADF7C271-A66E-4B6C-BC9A-908461DDD979 Q34666066-46BAC34F-8563-4BFF-9035-E5A3A8912B91 Q34721223-649F0269-1FFC-41BB-8CB5-4F3FE9C0CDC8 Q35454043-59B57395-BE3C-4997-84B6-7F475882B219 Q36130646-BF666C67-DD25-4AC0-B67E-BDFB3AD3C877 Q36276815-67AEBC34-D351-4380-8B21-B63A2F69DA9A Q36546331-7002863B-CCB1-4D37-AF59-DDB9582FAF28 Q36788809-02BC01ED-B9AE-4DD9-8E4C-3758F32D284D Q36944786-0D0D591C-3D4A-49A7-8588-EF11CA07CEAA Q37031224-13F070A5-7881-4469-B838-A7AD76DCD087 Q37100264-F4279483-10D9-4821-938F-82A1D22C6B14 Q37226360-2A8852AB-7BFC-4A85-B63E-8C09CAAF25C7 Q37451165-1DE1A7F5-B6B3-497E-9085-591379671B06 Q37656951-C0EE6D2C-946D-4361-B38A-D4BE74C51780 Q37690735-78951550-8EF9-4CC8-A6F4-D9DC401318F2 Q38230276-1C903174-D234-49A1-ADB9-DA531579A599 Q38543690-3A4971EA-DB94-4DE2-B951-698FDFA1AF8E Q38543692-BE96D822-D787-431E-AD80-704E37115091 Q38630663-52E4F606-0AF7-4FCA-BD3A-734BD997B0A5 Q38952138-9F8CCFCA-4752-4491-932A-16370773668C Q38979780-95A90819-0B28-4362-B088-DC6A9E442C1B Q39021248-FC4DB7FC-6CC5-4882-BE34-E906114C8FF2 Q39044741-C480B179-6404-4E4C-86FD-D836A0E42694 Q39450087-1B563FBC-13A2-4EB2-8737-9F4A613FC3A8 Q40043509-ECF37011-9B41-4842-994E-BCC8469FD7C2 Q40241820-4C85429A-0C46-4E5B-A51E-891A4341409A Q40656308-78A8A9B8-2CF7-42A0-98C4-DBF6CA15D688 Q41105228-EB2AE130-72E0-4CA4-9316-9B60F841B448 Q41187671-3087BD8E-4AD7-431E-AB17-52FC41281B5C Q44584276-86ACA0F3-7B52-43E7-B384-81960C8E82C6 Q47645232-A5C2449B-525C-4329-A1EB-84E3B3B90338 Q48501021-594DE28B-ADD8-4E73-A64F-069F0394065E

P2860

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

http://www.wikidata.org/entity/Q34159164

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Close temporal relationship be ...... A polymerase I/III antibodies.

@ast

Close temporal relationship be ...... A polymerase I/III antibodies.

@en

Close temporal relationship be ...... A polymerase I/III antibodies.

@nl

type

label

Close temporal relationship be ...... A polymerase I/III antibodies.

@ast

Close temporal relationship be ...... A polymerase I/III antibodies.

@en

Close temporal relationship be ...... A polymerase I/III antibodies.

@nl

prefLabel

Close temporal relationship be ...... A polymerase I/III antibodies.

@ast

Close temporal relationship be ...... A polymerase I/III antibodies.

@en

Close temporal relationship be ...... A polymerase I/III antibodies.

@nl

P1433

Q34159164-98216F6E-93DD-4C6D-A9DE-313D209B1653

P1476

Q34159164-ABE4F7AB-874E-45E0-8989-59AD23879EDD

P2093

Q34159164-3C975FA2-7DF2-4B29-88F0-8685B83A81E8

Q34159164-83AD6C76-47DB-465B-97F4-CB0B0DA05396

Q34159164-8FC21568-1357-427C-9C13-5A7FF0196737

Q34159164-A9593D25-7788-4D95-96B9-30B1AA1853D2

P2860

Q34159164-0A387307-4C06-4771-8A13-463214E9CC7F

Q34159164-0BD4E8A9-9FEC-4AFD-9E27-0DC084387D41

Q34159164-2271F308-70D8-47FF-B661-0740A7582F4B

Q34159164-28E9FEA5-AD65-4D86-A599-A182CAEA9BA8

Q34159164-2CCF0046-DA4A-4A07-813D-F0F5B2213F8B

Q34159164-345EF629-0182-4E9B-8042-88B5990E2657

Q34159164-36CA8F51-6360-4031-9EE4-E6C5199F31BB

Q34159164-49322CDC-9B38-48E5-8838-247E991689E6

Q34159164-5462306D-960C-4AC3-B7E8-56FA44E7D10E

Q34159164-5662219E-0206-46C7-8F13-6D8F7E7D21B9

P304

Q34159164-54261067-8160-4B01-BCD1-504FB50D7448

P31

Q34159164-984410D7-6FDC-4A84-BD95-22CF89BB38D5

P356

Q34159164-A9525F5A-171F-428C-A317-1381A041DC57

P433

Q34159164-C1C2B81A-AA9D-4330-94E4-BDE0C40A8E93

P478

Q34159164-ABB98F48-157F-43B9-90B2-39C6D9CF5B15

P50

Q34159164-F35B514E-AF6A-469B-8360-58C673B762D9

P577

Q34159164-F4B932C7-4469-41C1-B105-3DCECABF149D

P5875

Q34159164-9A1CC5F8-0608-4049-BD6F-D967945788EC

P698

Q34159164-F711664C-66AB-4F5A-8BC5-C9C6F2B17697

P921

Q34159164-2BC08F8F-C37C-4CFA-9B2E-B8ED6A14D53B

Q34159164-6DD3C12F-C75D-4132-A310-E0EB4762CD16

P932

Q34159164-03829C12-229A-46F1-BC7D-A747803FD513

P356

P1433

Arthritis and Rheumatism

P1476

Close temporal relationship be ...... NA polymerase I/III antibodies

@en

P2093

Ami A Shah

http://www.w3.org/2001/XMLSchema#string

Antony Rosen

http://www.w3.org/2001/XMLSchema#string

Fredrick Wigley

http://www.w3.org/2001/XMLSchema#string

Livia Casciola-Rosen

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit.

Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.

Risk of cancer in patients with scleroderma: a population based cohort study

Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.

Risk factors for lung cancer in patients with scleroderma: a nested case-control study.

Association between systemic sclerosis and breast cancer: eight new cases and review of the literature.

Breast cancer and scleroderma.

P304

2787-2795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.27549

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Laura K. Hummers

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44634153

http://www.w3.org/2001/XMLSchema#string

P698

20506513

http://www.w3.org/2001/XMLSchema#string

P921

P932

2946521

http://www.w3.org/2001/XMLSchema#string